Effect of lenalidomide (Revlimid) in solid tumour patients with inflammatory cancer cachexia syndrome on lean body mass and muscle strength: A multicenter, proof-of-concept study of fixed dose or CRP-response-guided dose of lenalidomide in relation to new standard basic cachexia management (receiving placebo) EKSG 09/40; CTU-11006 - Project - Authors - KSSG Research Database

Project

Effect of lenalidomide (Revlimid) in solid tumour patients with inflammatory cancer cachexia syndrome on lean body mass and muscle strength: A multicenter, proof-of-concept study of fixed dose or CRP-response-guided dose of lenalidomide in relation to new standard basic cachexia management (receiving placebo) EKSG 09/40; CTU-11006

Aborted · 2009 until 2012

Strasser Florian, Gueller Ulrich, Wilm Simone

Strasser, Florian

scientist (group leader)
Zentrum für Integrative Medizin · Dept. I

Gueller, Ulrich

Wilm, Simone